National Health Investors (NYSE:NHI) Price Target Raised to $92.00

National Health Investors (NYSE:NHI) had its price objective lifted by research analysts at Truist Financial from $85.00 to $92.00 in a research report issued on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the real estate investment trust’s stock. Truist Financial’s price objective would indicate a potential upside of 6.46% from the company’s previous close.

A number of other equities analysts also recently commented on the stock. Wells Fargo & Company boosted their target price on shares of National Health Investors from $80.00 to $85.00 and gave the stock an “equal weight” rating in a report on Tuesday, November 25th. Deutsche Bank Aktiengesellschaft downgraded shares of National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 price objective on the stock. in a research report on Tuesday, January 20th. KeyCorp boosted their price objective on shares of National Health Investors from $80.00 to $88.00 and gave the stock an “overweight” rating in a research note on Thursday, December 4th. Weiss Ratings restated a “buy (b)” rating on shares of National Health Investors in a research note on Monday, December 29th. Finally, National Bank Financial set a $85.00 price target on National Health Investors in a research report on Tuesday, January 20th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, National Health Investors currently has a consensus rating of “Moderate Buy” and a consensus price target of $86.86.

National Health Investors Stock Up 1.4%

NYSE:NHI traded up $1.21 during trading hours on Thursday, reaching $86.42. The company’s stock had a trading volume of 36,198 shares, compared to its average volume of 266,739. The stock has a 50 day moving average price of $83.09 and a two-hundred day moving average price of $79.27. The company has a debt-to-equity ratio of 0.76, a quick ratio of 6.90 and a current ratio of 6.90. The company has a market capitalization of $4.18 billion, a P/E ratio of 28.62, a price-to-earnings-growth ratio of 4.63 and a beta of 0.65. National Health Investors has a 12 month low of $66.41 and a 12 month high of $91.38.

National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Thursday, February 26th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.01). The company had revenue of $105.82 million during the quarter, compared to analysts’ expectations of $95.12 million. National Health Investors had a net margin of 37.81% and a return on equity of 9.56%. The company’s revenue was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.24 earnings per share. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. Equities analysts predict that National Health Investors will post 4.41 EPS for the current fiscal year.

Institutional Investors Weigh In On National Health Investors

Institutional investors and hedge funds have recently made changes to their positions in the stock. NewEdge Advisors LLC raised its holdings in shares of National Health Investors by 28.7% during the first quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock worth $114,000 after purchasing an additional 345 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in National Health Investors by 9.6% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 249,937 shares of the real estate investment trust’s stock worth $18,460,000 after purchasing an additional 21,851 shares during the period. Jane Street Group LLC raised its stake in shares of National Health Investors by 1,728.4% during the 1st quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust’s stock valued at $5,148,000 after buying an additional 65,885 shares during the last quarter. Envestnet Asset Management Inc. lifted its holdings in shares of National Health Investors by 12.2% in the 2nd quarter. Envestnet Asset Management Inc. now owns 10,911 shares of the real estate investment trust’s stock valued at $765,000 after buying an additional 1,183 shares during the period. Finally, Bank of New York Mellon Corp boosted its stake in shares of National Health Investors by 3.2% in the second quarter. Bank of New York Mellon Corp now owns 607,913 shares of the real estate investment trust’s stock worth $42,627,000 after buying an additional 19,042 shares during the last quarter. 62.51% of the stock is currently owned by institutional investors and hedge funds.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.